Insider · CIK 0001889687
Xia Ding
director
Files at USNA (USANA HEALTH SCIENCES INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2025 | USNA USANA HEALTH SCIENCES INC | AGrant or award Restricted Stock Unitsderivative | +4,230 | $0.00 | $0 | 4,230 | May 21, 2025 |
| May 2, 2025 | USNA USANA HEALTH SCIENCES INC | MOption exercise Common Stock | +674 | - | - | 4,713 | May 6, 2025 |
| May 2, 2025 | USNA USANA HEALTH SCIENCES INC | FTax withholding Common Stock | -169 | $29.44 | $4,975 | 4,544 | May 6, 2025 |
| May 2, 2025 | USNA USANA HEALTH SCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -674 | $0.00 | $0 | 0 | May 6, 2025 |
| Feb 2, 2025 | USNA USANA HEALTH SCIENCES INC | MOption exercise Common Stock | +674 | - | - | 4,208 | Feb 3, 2025 |
| Feb 2, 2025 | USNA USANA HEALTH SCIENCES INC | FTax withholding Common Stock | -169 | $32.57 | $5,504 | 4,039 | Feb 3, 2025 |
| Feb 2, 2025 | USNA USANA HEALTH SCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -674 | $0.00 | $0 | 674 | Feb 3, 2025 |
| Nov 2, 2024 | USNA USANA HEALTH SCIENCES INC | MOption exercise Common Stock | +675 | - | - | 3,703 | Nov 5, 2024 |
| Nov 2, 2024 | USNA USANA HEALTH SCIENCES INC | FTax withholding Common Stock | -169 | $37.29 | $6,302 | 3,534 | Nov 5, 2024 |
| Nov 2, 2024 | USNA USANA HEALTH SCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -675 | $0.00 | $0 | 1,348 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.